Company Name: |
BOC Sciences
|
Tel: |
|
Email: |
info@bocsci.com |
Products Intro: |
Product Name:Piriprost potassium salt CAS:88851-62-1 Purity:≥98% Remarks:Piriprost is a structural analog of prostaglandin I2 (PGI2) and an inhibitor of 5-lipoxygenase (5-LO). Piriprost suppresses the synthesis of leukotrienes.
|
Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
Tel: |
18818260767 |
Email: |
sales@chemegen.com |
Products Intro: |
Product Name:Piriprost potassium salt CAS:88851-62-1 Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
Company Name: |
MedBioPharmaceutical Technology Inc
|
Tel: |
021-69568360 18916172912 |
Email: |
order@med-bio.cn |
Products Intro: |
Product Name:PIRIPROST POTASSIUM SALT CAS:88851-62-1 Purity:98% Package:10mg; 50mg; 5mg Remarks:Medbio
|
|
| PIRIPROST POTASSIUM SALT Basic information |
Product Name: | PIRIPROST POTASSIUM SALT | Synonyms: | [4R-[4A(1E,3S*),5B]]-1,4,5,6-TETRAHYDRO-5-HYDROXY-4-(3-HYDROXY-1-OCTENYL)-1-PHENYL-CYCLOPENTA[B]PYRROLE-2-PENTANOIC ACID, POTASSIUM SALT;1,4(R),5(R),6-TETRAHYDRO-5-HYDROXY-4-[(1E,3S)-HYDROXY-1-OCTENYL]-1-PHENYL-CYCLOPENTA[B]PYRROLE-2-PENTANOIC ACID, MONOPOTASSIUM SALT;PIRIPROST POTASSIUM SALT;U-60257B;U60,257B POTASSIUM SALT;[4r-[4α(1e,3s*),5β]]-1,4,5,6-tetrahydro-5-hydroxy-4-(3-hydroxy-1-octenyl)-1-phenyl-cyclopenta[b]pyrrole-2-pentanoic acid, potassium salt;U60,257B, [4R-[4α(1E,3S*),5β]]-1,4,5,6-Tetrahydro-5-hydroxy-4-(3-hydroxy-1-octenyl)-1-phenyl-cyclopenta[b]pyrrole-2-pentanoic acid, potassium salt;potassium:5-[(4R,5R)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-1-phenyl-5,6-dihydro-4H-cyclopenta[b]pyrrol-2-yl]pentanoate | CAS: | 88851-62-1 | MF: | C26H34KNO4 | MW: | 463.65 | EINECS: | | Product Categories: | | Mol File: | 88851-62-1.mol | |
| PIRIPROST POTASSIUM SALT Chemical Properties |
storage temp. | −20°C | solubility | ≤43mg/ml in ethanol;30mg/ml in DMSO;8.6mg/ml in dimethyl formamide | form | solid |
| PIRIPROST POTASSIUM SALT Usage And Synthesis |
Uses | Piriprost Potassium is a structural analog of prostaglandin I2. | Uses | Antiasthmatic. | Biological Activity | piriprost (u 60257) is a leukotriene synthesis inhibitor [1].leukotrienes belong to a family of eicosanoid inflammatory mediators produced in leukocytes. leukotrienes mainly act on a subfamily of g protein-coupled receptors. the production of leukotrienes is implicated in triggerring contractions in the smooth muscles lining the bronchioles and is a major cause of inflammation in asthma and allergic rhinitis [2].piriprost inhibited the formation of 5-hydroxyeicosatetraenoic acid (5-hete), ltb4, and the sulfidopeptide leukotrienes with the ic50 values ranged from 9 to 14 μm for the mouse mast cells and 15-50 μm for the basophil leukemia cells. piriprost weakly inhibited the solubilized ltc synthase of rat basophil leukemia cells with the ic50 of 1.5 mm [1]. piriprost increased alkaline phosphatase (alp) activity in cultured endometrial stromal cells. piriprost (100 μm) inhibited 5-lipoxygenase activity and decreased 5-hydroxy-eicosatetraenoic acid (a 5-lipoxygenase product) by 53% [3].in smoke-exposed rabbits, pretreatment with piriprost attenuated the smoke-induced increase in alveolar-capillary barrier permeability and decrease in plasminogen activator activity and causes a swelling of type i alveolar epithelium [4]. | references | [1] bach m k, brashler j r, white g j, et al. experiments on the mode of action of piriprost (u-60,257), an inhibitor of leukotriene formation in cloned mouse mast cells and in rat basophil leukemia cells[j]. biochemical pharmacology, 1987, 36(9): 1461-1466. [2] smith m j h, ford‐hutchinson a w, bray m a. leukotriene b: a potential mediator of inflammation[j]. journal of pharmacy and pharmacology, 1980, 32(1): 517-518. [3] cejic s s, kennedy t g. examination of the effects of piriprost (u-60,257 b) on alkaline phosphatase activity of rat endometrial stromal cells in vitro[j]. prostaglandins, 1991, 42(2): 179-189. [4] itten m l, grad r, quan s f, et al. piriprost pretreatment attenuates the smoke-induced increase in 99mtcdtpa lung clearance[j]. experimental lung research, 1990, 16(4): 339-353. |
| PIRIPROST POTASSIUM SALT Preparation Products And Raw materials |
|